RenJi Hospital: Pancreatic Neoplasms trials

The registry lists 14 Pancreatic Neoplasms studies with RenJi Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 4Phase 3 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in ChinaNot yet recruitingNCT07026123
• Target-specific immunoPET Imaging of Digestive System CarcinomaRecruitingNCT06715839Not applicable
• Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)Not yet recruitingNCT06621095Phase 2
• ImmunoPET Imaging of Pancreatic CancerRecruitingNCT06602037Not applicable
• Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine DifferentiationNot yet recruitingNCT06531291Phase 2
• A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.Status unknownNCT05346146Phase 2
• Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image DataStatus unknownNCT05313854
• Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data CenterStatus unknownNCT05141656
• A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer PatientsStatus unknownNCT05138302
• A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerStatus unknownNCT04674956Phase 3
• An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT04310553Not applicable
• The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic CancerStatus unknownNCT04183478Phase 2/3
• SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerCompletedNCT04181645Not applicable
• The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic CancerStatus unknownNCT03076502